Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-023370

IRADIMED CORP · IRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Steven M. Nardi
Officer — VP of Manufacturing
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 30, 2017A1,934$1.48A2,194D
Common StockF1May 30, 2017S1,934$8.345D260D
Common StockJun 1, 2017A2,440$1.48A2,700D
Common StockJun 1, 2017S2,700$8.30D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$1.48May 30, 2017M1,934A—Dec 31, 2023Common Stock1,9342,441D
Stock Option (Right to Buy)F2$1.48Jun 1, 2017M253A—Dec 31, 2023Common Stock2532,188D
Stock Option (Right to Buy)F3$1.48Jun 1, 2017M2,187A—Dec 13, 2023Common Stock2,1872,188D

Explanation of responses